Norges Bank Deciphera Pharmaceuticals, Inc. Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
BUY
$10.11 - $16.54 $3.56 Million - $5.82 Million
352,000 New
352,000 $5.68 Million
Q3 2023

Nov 13, 2024
BUY
$12.46 - $15.48 $4.39 Million - $5.45 Million
352,068 New
352,068 $4.48 Million
Q2 2023

Aug 14, 2024
BUY
$13.28 - $15.96 $4.68 Million - $5.62 Million
352,068 New
352,068 $4.96 Million
Q1 2023

May 15, 2024
BUY
$14.26 - $22.1 $4.09 Million - $6.34 Million
287,068 New
287,068 $4.44 Million
Q1 2022

May 09, 2022
SELL
$6.87 - $11.11 $2.53 Million - $4.09 Million
-368,042 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$7.7 - $37.13 $2.83 Million - $13.7 Million
368,042 New
368,042 $3.6 Million
Q3 2021

Nov 14, 2022
BUY
$26.46 - $37.15 $9.74 Million - $13.7 Million
368,042 New
368,042 $12.5 Million
Q3 2021

Nov 05, 2021
SELL
$26.46 - $37.15 $10 Million - $14 Million
-377,879 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$32.73 - $47.95 $12.4 Million - $18.1 Million
377,879 New
377,879 $13.8 Million
Q2 2021

Aug 10, 2021
SELL
$32.73 - $47.95 $10.6 Million - $15.6 Million
-324,868 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$40.39 - $56.73 $13.1 Million - $18.4 Million
324,868 New
324,868 $14.6 Million
Q1 2021

May 07, 2021
SELL
$40.39 - $56.73 $17.5 Million - $24.6 Million
-433,882 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$51.77 - $66.18 $22.5 Million - $28.7 Million
433,882 New
433,882 $24.8 Million
Q4 2020

Feb 10, 2021
SELL
$51.77 - $66.18 $23 Million - $29.4 Million
-444,860 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$43.8 - $58.16 $19.5 Million - $25.9 Million
444,860 New
444,860 $22.8 Million
Q3 2020

Nov 10, 2020
SELL
$43.8 - $58.16 $17 Million - $22.6 Million
-388,079 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$37.05 - $65.03 $14.4 Million - $25.2 Million
388,079 New
388,079 $23.2 Million
Q2 2020

Aug 07, 2020
SELL
$37.05 - $65.03 $6.65 Million - $11.7 Million
-179,355 Closed
0 $0
Q1 2020

May 07, 2021
SELL
$33.63 - $69.4 $5.14 Million - $10.6 Million
-152,906 Reduced 46.02%
179,355 $7.38 Million
Q4 2018

Mar 04, 2019
BUY
$19.08 - $36.14 $6.34 Million - $12 Million
332,261 New
332,261 $6.97 Million
Q4 2018

Feb 08, 2019
SELL
$19.08 - $36.14 $9.54 Million - $18.1 Million
-500,000 Closed
0 $0
Q3 2018

Nov 12, 2019
BUY
$33.57 - $42.1 $16.8 Million - $21.1 Million
500,000 New
500,000 $19.4 Million
Q3 2018

Nov 09, 2018
SELL
$33.57 - $42.1 $16.8 Million - $21.1 Million
-500,000 Closed
0 $0
Q2 2018

Aug 12, 2019
BUY
$20.06 - $44.95 $10 Million - $22.5 Million
500,000 New
500,000 $19.7 Million
Q2 2018

Jul 23, 2018
SELL
$20.06 - $44.95 $1.5 Million - $3.37 Million
-75,000 Closed
0 $0
Q1 2018

May 15, 2019
BUY
$20.04 - $29.71 $1.5 Million - $2.23 Million
75,000 New
75,000 $1.5 Million
Q1 2018

May 09, 2018
SELL
$20.04 - $29.71 $1.5 Million - $2.23 Million
-75,000 Closed
0 $0
Q4 2017

Mar 05, 2018
BUY
$16.54 - $24.2 $1.24 Million - $1.82 Million
75,000 New
75,000 $1.7 Million
Q4 2017

Feb 09, 2018
SELL
$16.54 - $24.2 $1.24 Million - $1.82 Million
-75,000 Closed
0 $0
Q3 2017

Nov 13, 2018
BUY
$17.65 - $18.99 $1.32 Million - $1.42 Million
75,000
75,000 $1.42 Million

Others Institutions Holding DCPH

# of Institutions
6
Shares Held
293K
Call Options Held
500
Put Options Held
0
View Full List

About Deciphera Pharmaceuticals, Inc.

DCPH Quotes by TradingView
  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email